pre-ipo
Stage
About
Evaxion uses its proprietary AI-Immunology™ platform to develop vaccine candidates focused on cancer and infectious diseases by decoding the human immune system for target discovery and drug design.
Explore Evaxion's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.